FAKTOR-OPTIONSSCHEIN - JOHNSON & JOHNSON Share Price

Certificat

DE000SB0XT70

Market Closed - Deutsche Boerse AG 20:46:51 31/05/2024 BST
1.29 EUR -3.73% Intraday chart for FAKTOR-OPTIONSSCHEIN - JOHNSON & JOHNSON
Current month-14.57%
1 month-14.57%
Date Price Change
31/05/24 1.29 -3.73%
30/05/24 1.34 -3.60%
29/05/24 1.39 +0.72%
28/05/24 1.38 +10.40%
27/05/24 1.25 -1.57%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 08:46 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying JOHNSON & JOHNSON
IssuerLogo Issuer Société Générale Société Générale
WKN SB0XT7
ISINDE000SB0XT70
Date issued 08/06/2020
Strike 146.7 $
Maturity Unlimited
Parity 1 : 1
Emission price 8.86
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 11.99
Lowest since issue 0.66
Spread 0.01
Spread %0.78%

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
146.7 USD
Average target price
171.9 USD
Spread / Average Target
+17.23%
Consensus